Atlas Trials

Efficacy of MND-2119 in Participants With Hypertriglyceridemia

Clinical trial NCT03693131 · COMPLETED

Trial details

NCT number
NCT03693131
Sponsor
Mochida Pharmaceutical Company, Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertriglyceridemia
Start date
2018-10-27
Primary completion
2019-06-15
Enrollment
580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.